NeuBase Therapeutics

    Approach: modular antisense peptide nucleic acid 

    Status: Preclinical

    Link to NeuBase's Pipeline

    Press Release announcing NeuBase-Ohr merger

    Dec. 16, 2020 Press Release announcing preclinical data